News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Andrews Timothy K.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/16/2021 |
4
| Andrews Timothy K. (General Counsel) has filed a Form 4 on Prometheus Biosciences, Inc.
Txns:
| Granted 54,132 options to buy
@ $36.32, valued at
$2M
|
|
03/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
08/08/2019 |
4
| Andrews Timothy K. (General Counsel & Secretary) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns:
| Granted 50,000 shares
@ $0 Disposed/sold 60,000 options to buy
@ $15.08, valued at
$904.8k
Disposed/sold 8,518 options to buy
@ $15, valued at
$127.8k
Disposed/sold 18,290 options to buy
@ $2.32, valued at
$42.4k
Disposed/sold 22,500 options to buy
@ $2.32, valued at
$52.2k
Granted 8,518 options to buy
@ $0.71, valued at
$6k
Granted 60,000 options to buy
@ $0.71, valued at
$42.6k
Granted 18,290 options to buy
@ $0.71, valued at
$13k
Granted 22,500 options to buy
@ $0.71, valued at
$16k
|
|
07/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2019 |
4
| Andrews Timothy K. (General Counsel & Secretary) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns:
| Granted 45,000 shares
@ $0 Granted 18,290 options to buy
@ $2.32, valued at
$42.4k
Granted 22,500 options to buy
@ $2.32, valued at
$52.2k
|
|
06/04/2018 |
4
| Andrews Timothy K. (General Counsel & Secretary) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.
Txns:
| Granted 60,000 options to buy
@ $15.08, valued at
$904.8k
|
|
08/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|